KR102685908B1 - Method for breeding millworm using styrofoam waste - Google Patents
Method for breeding millworm using styrofoam waste Download PDFInfo
- Publication number
- KR102685908B1 KR102685908B1 KR1020220005225A KR20220005225A KR102685908B1 KR 102685908 B1 KR102685908 B1 KR 102685908B1 KR 1020220005225 A KR1020220005225 A KR 1020220005225A KR 20220005225 A KR20220005225 A KR 20220005225A KR 102685908 B1 KR102685908 B1 KR 102685908B1
- Authority
- KR
- South Korea
- Prior art keywords
- module
- styrofoam
- growth
- mealworms
- week
- Prior art date
Links
- 229920006328 Styrofoam Polymers 0.000 title claims abstract description 76
- 239000008261 styrofoam Substances 0.000 title claims abstract description 76
- 238000000034 method Methods 0.000 title claims abstract description 31
- 238000009395 breeding Methods 0.000 title claims abstract description 21
- 230000001488 breeding effect Effects 0.000 title claims abstract description 21
- 239000002699 waste material Substances 0.000 title claims abstract description 16
- 230000006641 stabilisation Effects 0.000 claims abstract description 17
- 238000011105 stabilization Methods 0.000 claims abstract description 17
- 235000013601 eggs Nutrition 0.000 claims abstract description 13
- 235000015099 wheat brans Nutrition 0.000 claims abstract description 12
- 241000209140 Triticum Species 0.000 claims abstract description 7
- 235000021307 Triticum Nutrition 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 210000000936 intestine Anatomy 0.000 claims abstract description 5
- 238000002604 ultrasonography Methods 0.000 claims abstract description 5
- 238000007689 inspection Methods 0.000 claims abstract description 4
- 230000012447 hatching Effects 0.000 claims abstract description 3
- 230000017448 oviposition Effects 0.000 abstract description 7
- 210000000056 organ Anatomy 0.000 description 36
- 239000000843 powder Substances 0.000 description 36
- 238000012360 testing method Methods 0.000 description 31
- 210000004027 cell Anatomy 0.000 description 29
- 238000002474 experimental method Methods 0.000 description 23
- 241001465754 Metazoa Species 0.000 description 20
- 241000700159 Rattus Species 0.000 description 18
- 238000005259 measurement Methods 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 14
- 229940011871 estrogen Drugs 0.000 description 12
- 239000000262 estrogen Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 238000010876 biochemical test Methods 0.000 description 11
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 10
- 239000004794 expanded polystyrene Substances 0.000 description 10
- 235000021050 feed intake Nutrition 0.000 description 10
- 230000002489 hematologic effect Effects 0.000 description 10
- 230000037396 body weight Effects 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 230000035755 proliferation Effects 0.000 description 9
- 210000001541 thymus gland Anatomy 0.000 description 9
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 238000011888 autopsy Methods 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 238000004064 recycling Methods 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010060891 General symptom Diseases 0.000 description 5
- 230000004663 cell proliferation Effects 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 239000003651 drinking water Substances 0.000 description 5
- 235000020188 drinking water Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 5
- 229960005309 estradiol Drugs 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000001550 testis Anatomy 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 4
- 108010082126 Alanine transaminase Proteins 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 4
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 3
- 210000004100 adrenal gland Anatomy 0.000 description 3
- 238000003912 environmental pollution Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 210000000440 neutrophil Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000000384 rearing effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- VVJYUAYZJAKGRQ-UHFFFAOYSA-N 1-[4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C(O)C1 VVJYUAYZJAKGRQ-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 231100000002 MTT assay Toxicity 0.000 description 2
- 238000000134 MTT assay Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 210000000702 aorta abdominal Anatomy 0.000 description 2
- 210000003651 basophil Anatomy 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012468 concentrated sample Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 238000009304 pastoral farming Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- FTZIQBGFCYJWKA-UHFFFAOYSA-N 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Chemical compound S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 FTZIQBGFCYJWKA-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000025721 COVID-19 Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 238000001134 F-test Methods 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 230000002327 eosinophilic effect Effects 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000005431 greenhouse gas Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 231100000508 hormonal effect Toxicity 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000005830 kidney abnormality Effects 0.000 description 1
- 230000005817 liver abnormality Effects 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008791 toxic response Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/90—Feeding-stuffs specially adapted for particular animals for insects, e.g. bees or silkworms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Environmental Sciences (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
본 발명은 스티로폼 폐기물을 이용한 밀웜 사육 방법에 관한 것으로, 브리딩 모듈(10)의 산란모듈(11)에서 성충거저리를 1주일간 먹이를 주어 산란을 시키는 산란단계(S100); 상기 산란단계(S100)에서 산란된 알을 성충거저리의 배설물과 함께 수거하여 4구역으로 구성된 생육모듈(12-1, 12-2, 12-3, 12-4)의 첫번째 생육모듈(12-1)로 이송(쉬프트)시켜 밀기울과 배합하는 배합단계(S200); 상기 배합단계(S200)에서 1주일 동안 부화를 시키고 생육을 시킨 후 두번째 생육모듈(12-2)로 이송(쉬프트) 시키고, 상기 두번째 생육모듈(12-2)에서 1주일 동안 생육 후 세번째 생육모듈(12-3)로 이송시키고, 상기 세번째 생육모듈(12-3)에서 1주일 동안 생육을 시키고, 네번째 생육모듈(12-4)로 순차적으로 이송을 시키는 생육단계(S300); 상기 생육단계(S300)에서 4주 동안 성장한 애벌레는 피딩모듈(20-1~20-10)로 순차적으로 이송이 되어 10주 동안 스티로폼 케이크(110)를 섭취하면서 원하는 크기만큼의 애벌레로 성장을 하게 되는 피딩단계(S400); 상기 피딩단계(S400)에서 10주 동안 피딩모듈에서 성장한 애벌레는 안정화모듈(30)로 이송되어 5일간 밀기울만 먹이면서 체내의 스치로폼을 완전히 없애고, 2일 동안은 절식을 시켜 밀원의 장을 비우도록 하는 안정화단계(S500); 및 상기 안정화단계(S500)를 거친 밀웜의 스티로폼 체내 잔유물 존재여부를 확인하기 위하여 초음파, 엑스레이 등을 이용하여 표본 혹은 전수 검사하여 밀웜의 체내에 스티로폼 잔유물이 있는지를 검사하여 잔유물이 존재할 경우 2일 동안 추가로 절식을 시켜 잔유물을 완전히 제거하는 검사단계(S600);를 포함하는 것을 특징으로 한다.The present invention relates to a method of raising mealworms using Styrofoam waste, which includes an egg-laying step (S100) of feeding adult mealworms in the egg-laying module 11 of the breeding module 10 to lay eggs for one week; The eggs spawned in the spawning step (S100) are collected together with the excrement of adult mealworms and grown in the first growth module (12-1) of the growth modules (12-1, 12-2, 12-3, 12-4) composed of 4 zones. ) and mixing with wheat bran (S200); After hatching and growing for one week in the mixing step (S200), they are transferred (shifted) to the second growth module (12-2), and grown for one week in the second growth module (12-2) and then transferred to the third growth module. A growth step (S300) of transferring to (12-3), growing for one week in the third growth module (12-3), and sequentially transferring to the fourth growth module (12-4); The larvae that grew for 4 weeks in the growth stage (S300) are sequentially transferred to the feeding modules (20-1 to 20-10) and grow into larvae of the desired size while eating the Styrofoam cake (110) for 10 weeks. Feeding step (S400); In the feeding step (S400), the larvae that grew in the feeding module for 10 weeks are transferred to the stabilization module (30) and fed only with wheat bran for 5 days to completely eliminate Styrofoam in the body, and are fasted for 2 days to empty the intestines of the wheat source. Stabilization step (S500); And in order to check whether there is any Styrofoam residue in the body of the mealworm that has gone through the stabilization step (S500), a sample or all samples are examined using ultrasound, In addition, it is characterized by including an inspection step (S600) of completely removing residues by fasting.
Description
본 발명은 밀웜 사육 방법에 관한 것으로, 더욱 상세하게는 스티로폼 폐기물을 이용하여 밀웜을 사육하는 방법에 관한 것이다.The present invention relates to a method of raising mealworms, and more specifically, to a method of rearing mealworms using Styrofoam waste.
최근 코로나 19사태 이후로 급격한 배달사업의 성장으로 스티로폼이라 불리는 발포폴리스티렌(EPS: EXPANDED POLYSTYRENE)의 사용량이 급격히 증가함에 따라 스티로폼 폐기물로 인한 환경오염이 심각해지고 있다. Recently, due to the rapid growth of the delivery business since the COVID-19 incident, the use of expanded polystyrene (EPS: EXPANDED POLYSTYRENE), also called Styrofoam, has rapidly increased, and environmental pollution due to Styrofoam waste is becoming more serious.
이를 해결하기 위해 사용되는 스티로폼을 처리하는 기술로는 잉곳, 펠렛 등으로 재가공 하는 방식과 소각을 통한 열발전, 매립 등의 단순폐기방식이 사용되고 있으나, 스티로폼 재가공 제품의 가격인하로 단순폐기방식을 주로 사용하며 매립 시 500년 이상 자연 분해되지 아니하고, 또한 소각처리 시에는 다이옥신 등 발암물질의 발생으로 환경적인 문제점이 제기되어 전세계가 이러한 스티로폼을 처리할 수 있는 해결책이 요구되고 있다.Technologies for processing Styrofoam used to solve this problem include reprocessing it into ingots, pellets, etc., and simple disposal methods such as heat generation through incineration and landfill. However, due to the price reduction of reprocessed Styrofoam products, simple disposal methods are mainly used. When used in landfill, it does not naturally decompose for more than 500 years, and when incinerated, environmental problems are raised due to the generation of carcinogens such as dioxin, so the world is demanding a solution to dispose of such Styrofoam.
이러한 문제점을 해결하기 위한 한 수단으로서 스티로폼을 먹어서 분해할 수 있는 생명체인 밀웜(거저리 애벌레)을 이용하여 스티로폼을 분해시키는 생물학적 유기변환을 일으키는 방법이 소개되고 있으나 스티로폼을 먹고 자란 밀웜의 안전성에 대한 연구가 필요한 실정이다.As a means to solve this problem, a method of causing biological organic transformation to decompose Styrofoam using mealworms (mealworm larvae), a living organism that can decompose Styrofoam by eating it, has been introduced. However, research on the safety of mealworms that grew up eating Styrofoam has been introduced. is needed.
상기와 같은 문제점을 해결하기 위한 본 발명의 목적은 스티로폼 폐기물을 사료로 밀웜을 사육하여 환경 오염을 감소시킬 수 있는 스티로폼 폐기물을 이용한 밀웜 사육 방법을 제공하는 데 있다. The purpose of the present invention to solve the above problems is to provide a method of raising mealworms using Styrofoam waste, which can reduce environmental pollution by rearing mealworms using Styrofoam waste as feed.
상기 목적을 달성하기 위한 본 발명의 스티로폼 폐기물을 이용한 밀웜 사육 방법은 브리딩 모듈(10)의 산란모듈(11)에서 성충거저리를 1주일간 먹이를 주어 산란을 시키는 산란단계(S100); 상기 산란단계(S100)에서 산란된 알을 성충거저리의 배설물과 함께 수거하여 4구역으로 구성된 생육모듈(12-1, 12-2, 12-3, 12-4)의 첫번째 생육모듈(12-1)로 이송(쉬프트)시켜 밀기울과 배합하는 배합단계(S200); 상기 배합단계(S200)에서 1주일 동안 부화를 시키고 생육을 시킨 후 두번째 생육모듈(12-2)로 이송(쉬프트) 시키고, 상기 두번째 생육모듈(12-2)에서 1주일 동안 생육 후 세번째 생육모듈(12-3)로 이송시키고, 상기 세번째 생육모듈(12-3)에서 1주일 동안 생육을 시키고, 네번째 생육모듈(12-4)로 순차적으로 이송을 시키는 생육단계(S300); 상기 생육단계(S300)에서 4주 동안 성장한 애벌레는 피딩모듈(20-1~20-10)로 순차적으로 이송이 되어 10주 동안 스티로폼 케이크(110)를 섭취하면서 원하는 크기만큼의 애벌레로 성장을 하게 되는 피딩단계(S400); 상기 피딩단계(S400)에서 10주 동안 피딩모듈에서 성장한 애벌레는 안정화모듈(30)로 이송되어 5일간 밀기울만 먹이면서 체내의 스치로폼을 완전히 없애고, 2일 동안은 절식을 시켜 밀원의 장을 비우도록 하는 안정화단계(S500); 및 상기 안정화단계(S500)를 거친 밀웜의 스티로폼 체내 잔유물 존재여부를 확인하기 위하여 초음파, 엑스레이 등을 이용하여 표본 혹은 전수 검사하여 밀웜의 체내에 스티로폼 잔유물이 있는지를 검사하여 잔유물이 존재할 경우 2일 동안 추가로 절식을 시켜 잔유물을 완전히 제거하는 검사단계(S600);를 포함하는 것을 특징으로 한다.To achieve the above object, the method of raising mealworms using Styrofoam waste of the present invention includes an egg-laying step (S100) in which adult mealworms are fed for one week in the egg-laying module 11 of the breeding module 10 to lay eggs; The eggs spawned in the spawning step (S100) are collected together with the excrement of adult mealworms and grown in the first growth module (12-1) of the growth modules (12-1, 12-2, 12-3, 12-4) composed of 4 zones. ) and mixing with wheat bran (S200); After hatching and growing for one week in the mixing step (S200), they are transferred (shifted) to the second growth module (12-2), and grown for one week in the second growth module (12-2) and then transferred to the third growth module. A growth step (S300) of transferring to (12-3), growing for one week in the third growth module (12-3), and sequentially transferring to the fourth growth module (12-4); The larvae that grew for 4 weeks in the growth stage (S300) are sequentially transferred to the feeding modules (20-1 to 20-10) and grow into larvae of the desired size while eating the Styrofoam cake (110) for 10 weeks. Feeding step (S400); In the feeding step (S400), the larvae that grew in the feeding module for 10 weeks are transferred to the stabilization module (30) and fed only with wheat bran for 5 days to completely eliminate Styrofoam in the body, and are fasted for 2 days to empty the intestines of the wheat source. Stabilization step (S500); And in order to check whether there is any Styrofoam residue in the body of the mealworm that has gone through the stabilization step (S500), a sample or all samples are examined using ultrasound, In addition, it is characterized by including an inspection step (S600) of completely removing residues by fasting.
이러한 특징에 따르면, 본 발명은 스티로폼을 사료로 하여 밀웜을 사육할 수 있으며, 스티로폼을 사료로 활용함으로 인해 환경오염을 감소시킬 수 있다.According to these characteristics, the present invention can raise mealworms using Styrofoam as feed, and can reduce environmental pollution by using Styrofoam as feed.
또한 본 발명의 방법으로 사육된 밀웜은 독성이 없으므로 식용으로 활용이 가능하다.Additionally, mealworms reared by the method of the present invention are non-toxic and can be used for food.
도1은 본 발명의 일 실시예에 따른 스티로폼(EPS) 폐기물을 재활용하여 밀웜을 사육하는 것을 각 단계별로 구성한 구성도이다.
도 2는 본 발명의 일 실시예에 따른 스티로폼(EPS) 폐기물을 재활용하여 밀웜을 사육하기 위해 천공된 스티로폼 슬릿에 밀기울이 도포되어 있는 스티로폼 케이크의 도면이다.
도 3은 본 발명의 일 실시예에 따른 스티로폼(EPS) 폐기물을 재활용하여 밀웜을 사육하는 방법을 나타낸 순서도이다. Figure 1 is a diagram illustrating each step of raising mealworms by recycling Styrofoam (EPS) waste according to an embodiment of the present invention.
Figure 2 is a diagram of a Styrofoam cake in which wheat bran is applied to a perforated Styrofoam slit to raise mealworms by recycling Styrofoam (EPS) waste according to an embodiment of the present invention.
Figure 3 is a flowchart showing a method of raising mealworms by recycling Styrofoam (EPS) waste according to an embodiment of the present invention.
아래에서는 첨부한 도면을 참고로 하여 본 발명의 실시 예에 대하여 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다. 그리고 도면에서 본 발명을 명확하게 설명하기 위해서 설명과 관계없는 부분은 생략하였으며, 명세서 전체를 통하여 유사한 부분에 대해서는 유사한 도면 부호를 붙였다.Below, with reference to the attached drawings, embodiments of the present invention will be described in detail so that those skilled in the art can easily implement the present invention. However, the present invention may be implemented in many different forms and is not limited to the embodiments described herein. In order to clearly explain the present invention in the drawings, parts that are not related to the description are omitted, and similar parts are given similar reference numerals throughout the specification.
그러면 첨부한 도 1 내지 3을 참고로 본 발명의 스티로폼(EPS) 폐기물을 재활용하여 밀웜을 사육하는 방법에 대하여 상세히 설명한다.Then, with reference to the attached FIGS. 1 to 3, the method of raising mealworms by recycling Styrofoam (EPS) waste according to the present invention will be described in detail.
밀웜은 스티로폼을 분해할 수 있는 현재까지 발견된 유일한 생명체로 약 300만 마리의 밀웜은 1킬로그램(kg)의 스티로폼을 24시간 내에 유기 분해할 수 있으며, 동시에 밀웜은 단백질과 지방이 많은 고지방, 고단백의 식품으로 영양가가 높은 식품군으로 평가가 되고 있다. Mealworms are the only living organisms discovered to date that can decompose Styrofoam. Approximately 3 million mealworms can organically decompose 1 kilogram (kg) of Styrofoam within 24 hours. At the same time, mealworms are high in fat and high in protein and fat. It is evaluated as a food group with high nutritional value.
스티로폼(ESP)을 성공적으로 섭취한 후 배설물을 배설할 수 있는 시간 까지 통상적으로 적어도 24시간이 소요가 되며 48시간 내에는 완전히 배설이 된다. After successfully ingesting Styrofoam (ESP), it usually takes at least 24 hours to be able to excrete excrement, and it is completely excreted within 48 hours.
밀웜은 식약청으로부터 식품안정성 인정을 받은 정식식용식품으로 등록된 식용곤충으로, 밀웜은 밀 도정 부산물인 밀기울을 주식으로 하므로 곡물소비가 적고, 축산업에 비하여 적은 사육공간만 있으면 되고 특히 온실가스(Green House Gas) 발생량이 기존 축산업에 비하여 아주 적은 장점이 있다.Mealworms are edible insects that have been officially registered as edible food with food safety recognition from the Food and Drug Administration. Mealworms are based on bran, a by-product of wheat milling, so they consume less grain, require less breeding space compared to livestock farming, and especially produce greenhouse gases (Green House). It has the advantage that the amount of gas generated is very small compared to existing livestock farming.
그러나 스티로폼은 밀웜이 선호하는 식품이 아니기에 잘 먹지 못하고 먹는 속도도 느리고, 또한 밀웜 체내의 스티로폼 잔여성분의 제거 또한 문제가 되어 스티로폼을 재활용하여 밀웜을 사육하는 사업이 불가능하였다.However, since Styrofoam is not a food preferred by mealworms, they cannot eat it well and eat it slowly, and removal of Styrofoam residues from the mealworm's body was also a problem, making it impossible to raise mealworms by recycling Styrofoam.
따라서 본 발명에서는 스티로폼 폐기물의 오염부를 제거하고 두께가 5mm 내지 10mm의 슬릿 형상으로 가공하고, 슬릿에 천공을 형성하여 상기 천공된 스티로폼에 밀웜이 좋아하는 밀기울 등을 부착하여 스티로품 케이크를 제조하여 사용하였다.Therefore, in the present invention, the contaminated portion of Styrofoam waste was removed, processed into a slit shape with a thickness of 5 mm to 10 mm, a perforation was formed in the slit, and wheat bran, which mealworms like, was attached to the perforated Styrofoam to produce a Styrofoam cake. .
본 발명에서 스티로폼에 밀기울 등을 접착시키기 위하여 사용되는 접착제는 밀가루의 글루텐을 이용하여 만든 약한 점성이 있는 접착제를 사용하지만, 밀웜에 해가 되지 않는 물질이면 대체하여 사용될 수 있다.In the present invention, the adhesive used to bond wheat bran, etc. to Styrofoam is a weakly viscous adhesive made from wheat gluten, but any material that is not harmful to mealworms can be used instead.
도 1은 본 발명의 일 실시예에 따른 스티로폼(EPS) 폐기물을 이용한 밀웜 사육장치(100)는 브리딩모듈(110), 피딩모듈(120), 안정화모듈(130)을 포함하여 구성된 것으로, 상기 브리딩모듈(110)은 다시 산란모듈(111) 및 생육모듈(112)로 구분되며, 상기 산란모듈(111)에서는 성충거저리를 투입하여 폐기과일 등을 먹이로 제공하면서 배설물과 산란을 하도록 하며, 이때 산란된 알과 배설물은 메쉬망(미도시) 아래로 자연스럽게 낙하하도록 하여 성충거저리의 알과 배설물을 밀기울과 함께 배합하여 생육모듈(112)에서 4주 동안 생육을 시킨다.Figure 1 shows a mealworm breeding device 100 using Styrofoam (EPS) waste according to an embodiment of the present invention, which includes a breeding module 110, a feeding module 120, and a stabilization module 130, and the breeding The module 110 is further divided into an egg-laying module 111 and a growth module 112. In the egg-laying module 111, adult mealworms are introduced and discarded fruits, etc. are provided as food to excrete and lay eggs. At this time, they lay eggs. The eggs and excrement are allowed to naturally fall below the mesh net (not shown), and the eggs and excrement of adult mealworms are mixed with bran and grown in the growth module 112 for 4 weeks.
상기 생육모듈(112)에서 4주 동안 생육된 밀웜은 피딩모듈(120)로 이송되어 10주동안 스티로폼 케이크(110)를 섭취하면서 애벌레로 자라게 된다.The mealworms grown for 4 weeks in the growth module 112 are transferred to the feeding module 120 and grow into larvae while consuming the Styrofoam cake 110 for 10 weeks.
상기와 같이 14주동안 부화된 알에서부터 애벌레가 되고 나면 안정화모듈(130)에서는 상기 스티로폼 케이크(110)대신 일반 밀기울을 7일간 공급하여 밀웜의 몸 속에 존재하는 스티로폼의 잔여분을 완전히 분해하도록 안정화 기간을 거치게 한 후 최소한 이틀(2일) 동안 절식을 통하여 밀웜의 장을 비워 식용으로 가능하게 한다.After the eggs hatched for 14 weeks as described above become larvae, the stabilization module 130 supplies regular wheat bran instead of the Styrofoam cake 110 for 7 days to provide a stabilization period to completely decompose the remaining Styrofoam present in the body of the mealworm. After letting it go through the process, it fasts for at least two days to empty the intestines of the mealworm and make it edible.
또한 본 발명의 방법으로 사육한 밀웜의 스티로폼 체내 잔유물 존재여부를 확인하기 위하여 초음파, 엑스레이 등을 이용하여 표본 혹은 전수 검사하여 밀웜의 체내에 스티로폼 잔유물이 있는지를 검사하여 잔유물이 존재할 경우 일정시간(2일)을 추가로 절식을 시켜 잔유물을 완전히 제거하여 출하 또는 가공을 할 수 있도록 한다.In addition, in order to confirm the presence of Styrofoam residues in the body of mealworms reared by the method of the present invention, samples or all samples are examined using ultrasound, It is fasted for an additional day to completely remove residues so that it can be shipped or processed.
본 발명에서는 브리딩모듈(110)에서 4주간의 생육과정, 피딩모듈(120)에서 10주간의 사육과정 및 안정화 모듈(130)에서 7일간의 기간을 최적의 실시예로 하였으나 해당 국가나 지역의 기온과 습도 등에 따라 사육기간이 줄어들 수도 있고 더 늘어날 수도 있다.In the present invention, the optimal embodiment is a 4-week growth process in the breeding module 110, a 10-week breeding process in the feeding module 120, and a 7-day period in the stabilization module 130, but the temperature of the country or region Depending on the temperature and humidity, the breeding period may be shortened or extended.
그럼, 본 발명의 밀웜사육장치(100) 작동방법에 대해 도 1 및 도 3을 이용하여 구체적으로 설명을 하면, 우선 도 1의 브리딩 모듈(10)의 산란모듈(11)에서 성충거저리를 확보하여 1주일간 먹이를 주어 산란을 시키는 산란단계(S100), 상기 산란단계(S100)에서 산란된 알을 성충거저리의 배설물과 함께 수거하여 4구역으로 구성된 생육모듈(12-1, 12-2, 12-3, 12-4)의 첫번째 생육모듈(12-1)로 이송(쉬프트)시켜 밀기울과 배합하는 배합단계(S200), 상기 배합단계(S200)에서 1주일 동안 부화를 시키고 생육을 시킨 후 두번째 생육모듈(12-2)로 이송(쉬프트) 시키고, 상기 두번째 생육모듈(12-2)에서 1주일 동안 생육 후 세번째 생육모듈(12-3)로 이송시키고, 상기 세번째 생육모듈(12-3)에서 1주일 동안 생육을 시키고, 네번째 생육모듈(12-4)로 순차적으로 이송을 시키는 생육단계(S300), 상기 생육단계(S300)에서 4주 동안 성장한 애벌레는 피딩모듈(20-1~20-10)로 순차적으로 이송이 되어 10주동안 스티로폼 케이크(110)를 섭취하면서 원하는 크기만큼의 애벌레로 성장을 하게 되는 피딩단계(S400), 상기 피딩단계(S400)에서 10주동안 피딩모듈에서 성장한 애벌레는 안정화모듈(30)로 이송되어 5일간 밀기울만 먹이면서 체내의 스치로폼을 완전히 없애고, 2일 동안은 절식을 시켜 밀원의 장을 비우도록 하는 안정화단계(S500), 상기 안정화단계(S500)를 거친 밀웜의 스티로폼 체내 잔유물 존재여부를 확인하기 위하여 초음파, 엑스레이 등을 이용하여 표본 혹은 전수 검사하여 밀웜의 체내에 스티로폼 잔유물이 있는지를 검사하여 잔유물이 존재할 경우 일정시간(2일)을 추가로 절식을 시켜 잔유물을 완전히 제거하는 검사단계(S600)를 거치게 하여 최종 원하는 식용 가능한 애벌레를 확보할 수 있다. Now, if the operating method of the mealworm breeding device 100 of the present invention is explained in detail using FIGS. 1 and 3, first, adult mealworms are secured in the spawning module 11 of the breeding module 10 of FIG. A spawning stage (S100) in which eggs are fed by feeding them for one week, and the eggs spawned in the spawning stage (S100) are collected together with the excrement of adult mealworms and grown into a growth module (12-1, 12-2, 12-) consisting of 4 zones. 3, 12-4) is transferred (shifted) to the first growth module (12-1) and mixed with wheat bran (S200), hatched and grown for one week in the mixing step (S200), and then grown for the second time. Transferred (shifted) to the module 12-2, grown for one week in the second growth module 12-2, then transferred to the third growth module 12-3, and grown in the third growth module 12-3. The growth stage (S300) involves growing for one week and sequentially transferring to the fourth growth module (12-4). The larvae that grew for 4 weeks in the growth stage (S300) are fed to the feeding modules (20-1 to 20-10). ) and are sequentially transferred to the feeding stage (S400), where they grow into larvae of the desired size while consuming the Styrofoam cake (110) for 10 weeks. The larvae grown in the feeding module for 10 weeks in the feeding stage (S400) are A stabilization step (S500) in which the wheat worm is transported to the stabilization module (30) and fed only wheat bran for 5 days to completely eliminate Styrofoam in the body, and then fasted for 2 days to empty the intestines of the wheat worm. Meal worms that have gone through the stabilization step (S500) In order to check for the presence of Styrofoam residues in the mealworm's body, a sample or entire sample is inspected using ultrasound, The final desired edible larvae can be secured by going through an inspection step (S600) to completely remove them.
본 발명의 실시예대로 사육을 할 경우에는 처음 산란을 한 후 16주가 지나야 식용 가능한 애벌레를 얻을 수 있지만, 16주 이후부터는 매주마다 적어도 1억마리의 식용 밀웜을 확보 할 수 있다.When reared according to the embodiment of the present invention, edible larvae can be obtained only 16 weeks after the first egg laying, but after 16 weeks, at least 100 million edible mealworms can be secured every week.
이러한 식용 밀웜을 대량 생산하기 위해서는 본 발명 도 1의 밀웜사육장치(100)을 추가로 설치를 하게 되면 원하는 양 만큼의 식용 밀웜을 얻을 수 있다.In order to mass produce such edible mealworms, by additionally installing the mealworm breeding device 100 of FIG. 1 of the present invention, a desired amount of edible mealworms can be obtained.
상기와 같이 확보된 식용 밀웜은 일반적으로 살균과정, 건조과정을 거쳐 판매가 되거나, 분쇄과정 등이 추가로 거쳐 분말형태로 판매가 될 수 있다.Edible mealworms secured as described above are generally sold after going through a sterilization process and drying process, or can be sold in powder form after additionally going through a grinding process.
상기와 같은 방법으로 스티로폼(EPS) 폐기물을 재활용하여 사육한 밀웜을 분발형태로 제조한 시제품을 공주대학교 산업과학대학에 제공하여 세포 실험과 동물 실험을 통해 스티로폼을 급여한 밀웜 분말 가루의 안전성을 확인한 결과, 세포에 대하여 에스트로겐(estrogen)의 영향은 없는 것으로 사료되며, 수컷 쥐(rat)에 대해서도 독성을 나타내지 않는 것으로 결과가 나왔다. A prototype made from powdered mealworms raised by recycling Styrofoam (EPS) waste in the same manner as above was provided to the College of Industrial Sciences at Kongju University, and the safety of mealworm powder fed with Styrofoam was confirmed through cell and animal experiments. As a result, it appears that there is no effect of estrogen on cells, and the results show that it is not toxic to male rats.
이를 증명하기 위해서 공주대학교 산업과학 대학에서 실시한 연구내용의 중요한 부분을 상세히 기술하면 아래와 같다. To prove this, the important parts of the research conducted by the College of Industrial Sciences at Kongju National University are described in detail as follows.
[연구내용 주요부분][Main parts of the research]
2.1. 연구 내용2.1. Research content
스티로폼 분해에 사용한 밀웜의 사료로써의 안전성 평가를 위하여 세포에서 호르몬 영향 여부 그리고 실험동물에서 투여에 의한 독성 여부를 판단하기 위한 실험이다.In order to evaluate the safety of mealworms used to decompose Styrofoam as feed, this is an experiment to determine whether there is a hormonal effect on cells and whether there is toxicity when administered to experimental animals.
2.2. 연구 목적2.2. Study Purpose
본 시험은 세포 실험 및 동물실험 모델에서 스티로품 급여 밀웜 분말 가루의 안전성 평가를 위해 에스트로겐(estrogen) 의존성 세포 및 흰 쥐에 투여 또는 급여 후 안전성을 확인하는데 목적이 있다.The purpose of this test is to determine the safety of Styrofoam-fed mealworm powder after administration or feeding to estrogen-dependent cells and white rats in cell and animal test models.
3. 실험 재료 및 방법3. Experimental materials and methods
3.1 실험 재료3.1 Experimental materials
본 실험에서 사용한 밀웜 분말 가루는 제공받아 사용하였다.The mealworm powder used in this experiment was provided and used.
3.1.1 세포주: MCF-73.1.1 Cell line: MCF-7
MCF-7은 인간유래 유방암 세포로, 내분비계 장애 관련 실험 중 특히 에스트로겐(estrogen) 관련 실험에 많이 사용되며, 에스트로겐 수용체(estrogen receptor)가 존재하여 이에 따라 에스트로겐(estrogen) 존재 여부에 세포 증식 반응을 확인한다.MCF-7 is a human-derived breast cancer cell that is often used in experiments related to endocrine disorders, especially those related to estrogen. It has an estrogen receptor and thus responds to cell proliferation in the presence of estrogen. Confirm.
17-β에스트라디올(estradiol)은 에스트로겐(estrogen) 유도 분석에서 양성 대조군으로 사용되는 물질로 사용되며, 17-β에스트라디올(estradiol)에 노출되면 유방암 발병률과 증식이 증가한다.17-β estradiol is used as a positive control in estrogen induction assays, and exposure to 17-β estradiol increases the incidence and proliferation of breast cancer.
삭제delete
3.2 실험 방법3.2 Experimental method
3.2.1 밀웜으로부터 추출물 제조3.2.1 Preparation of extract from mealworms
감압농축 방법을 이용하여 밀웜 분말 가루로부터 유효성분을 추출한다.The active ingredient is extracted from mealworm powder using a reduced pressure concentration method.
살아있는 세포의 미토콘드리아 탈수소 효소작용에 의하여 노란색 수용성 기질인 엠티티(MTT) 테트라졸리움(tetrazolium)을 청자색을 띄는 비수용성의 formazan cystal로 환원시키는 미토콘드리아의 능력을 이용한 검사법이다.This is a test that uses the ability of mitochondria to reduce the yellow water-soluble substrate MTT tetrazolium to bluish-purple non-water-soluble formazan cystal by the action of mitochondrial dehydrogenase in living cells.
3.2.2 MTT assay 3.2.2 MTT assay
MTT assay는 세포 독성 및 생존율을 측정하는 실험방법이다.MTT assay is an experimental method that measures cell toxicity and survival rate.
감압농축 방법을 이용하여 밀웜 분말 가루로부터 유효성분을 추출한다.The active ingredient is extracted from mealworm powder using a reduced pressure concentration method.
3.2.3 실험동물3.2.3 Experimental animals
실험종 및 계통: Rat, Sprague-Dawley (Crl:CD(SD)), male, 4주령(4wk)Experimental species and strain: Rat, Sprague-Dawley (Crl:CD(SD)), male, 4 weeks old (4wk)
생산자: Nara-Biotech INC., Korea Producer: Nara-Biotech INC., Korea
실험계 선정이유 Reasons for selecting the experimental system
선행연구들에서 쥐(SD rat)를 이용한 밀웜 분말 가루의 안전성 평가가 이루어지고 있으며, 쥐(rat)는 아급성 독성 시험에 지금까지 많이 사용되어 왔기 때문에 비교할 많은 생리, 해부 및 독성학적 기초 자료가 있어서 선택하였다.In previous studies, the safety of mealworm powder has been evaluated using rats (SD rats), and rats have been widely used in subacute toxicity tests so far, so there is a lot of physiological, anatomical, and toxicological basic data to compare. I chose it because it was there.
검역 및 순화 Quarantine and Purification
입수 시 4주령 쥐(rat)의 외관검사를 실시하고 전자저울로 체중을 측정한 후 6~7일간 순화기간을 두어 매일 1회 일반증상 관찰을 실시한다. 입수 시 쥐(rat)의 꼬리에 흑색 유성펜으로 개체 표시를 하고 군 분리 시에는 청색 유성펜으로 개체를 표시한다. Upon acquisition, a 4-week-old rat is inspected externally, its weight is measured using an electronic scale, and general symptoms are observed once a day after an acclimatization period of 6 to 7 days. Upon acquisition, the tail of the rat is marked with a black permanent marker, and when separating into groups, the individual is marked with a blue permanent marker.
군분리military separation
순화된 동물 중 체중 및 일반증상에 이상이 없는 개체를 선별하여 각각 군당 5마리씩 5군으로 분리한다. Among the purified animals, those with no abnormalities in weight or general symptoms are selected and separated into 5 groups with 5 animals per group.
사육조건Breeding conditions
사육 상자는 260W × 350D × 210H mm 의 스테인리스 철망 사육 상자를 사용하며, 온도 22 ± 3 ℃, 상대습도 30.0 ~ 70.0%, 조명시간 12시간 (07:00점등 ~ 19:00 소등), 조도 150 ~ 300 lux, 환기횟수 10 ~ 15 회/h로 설정된 공주대학교 동물실(A323)에서 진행하였다. 모든 시험은 공주대학교 IACUC (KNU_2021-08)에 따라 진행되었다.The breeding box uses a stainless steel wire mesh breeding box of 260W The study was conducted in the animal room (A323) of Kongju University, which was set at 300 lux and ventilation frequency of 10 to 15 times/h. All tests were conducted in accordance with Kongju National University IACUC (KNU_2021-08).
투여방법Administration method
투여 경로는 경구 투여로 임상적용 예상경로인 경구투여를 선택하였으며, 1일 1회, 5주간 총 35일간 투여한다. 투여 시간은 오전 10:00-11:00시로 투여전 위에 부담을 최소화 하기 위해 12시간 절식 후 투여를 진행 한다.The route of administration was oral administration, which is the route expected for clinical application. It is administered once a day for 5 weeks for a total of 35 days. The administration time is 10:00-11:00 am and is administered after fasting for 12 hours to minimize the burden on the stomach.
관찰 항목Observation Item
(1) 일반증상 관찰: 시험 기간 중에 1일 1회 실시한다. 관찰방법은 일반 임상증상의 여부 (anorexia, salivation, diarrhea, polyuria, anuria, fecal change 등)에 따라 그 정도 등을 기록한다.(1) General symptom observation: Conducted once a day during the test period. The observation method records the severity depending on the presence or absence of general clinical symptoms (anorexia, salivation, diarrhea, polyuria, anuria, fecal change, etc.).
(2) 체중 측정: 모든 동물에 대하여 투여 개시 전, 투여 개시 후, 시험종료 시까지 매주 2회 측정한다.(2) Body weight measurement: All animals are measured twice a week before the start of administration, after the start of administration, and until the end of the test.
(3) 사료 섭취량 측정: 사육상자별로 급여총량과 잔량을 투여개시 후 5주간 주 2회 측정한다.(3) Measurement of feed intake: The total amount fed and the remaining amount for each breeding box are measured twice a week for 5 weeks after the start of administration.
(4) 음수 섭취량 측정: 사육상자별로 급수총량과 잔량을 투여개시후 5주간 주 2회 측정한다.(4) Measurement of water intake: Measure the total amount and remaining amount of water in each breeding box twice a week for 5 weeks after the start of administration.
(5) 안과학적 검사: 투여기간중 무작위로 각군당 5마리씩의 동물에 대하여 육안 및 검안경을 이용한 안과학적 검사를 1회 실시한다.(5) Ophthalmological examination: During the administration period, an ophthalmological examination using the naked eye and an ophthalmoscope is performed once on five animals in each group at random.
(6) 혈액학적 및 혈청 생화학적 검사: 일반 혈액학적 검사 및 혈청 생화학적 검사를 진행한다.(6) Hematological and serum biochemical tests: General hematological tests and serum biochemical tests are performed.
(7) 장기중량측정: 시험동물에 대하여 신장(좌우), 비장, 심장, 부신(좌우), 정소(좌우), 폐장, 흉선 등의 체중에 대한 절대장기 중량 및 상대장기 중량을 측정한다.(7) Organ weight measurement: Absolute organ weight and relative organ weight are measured for the body weight of the test animal, including kidneys (left and right), spleen, heart, adrenal glands (left and right), testes (left and right), lungs, and thymus.
(8) 병리조직검사: 장기중량 측정이 끝난 모든 장기는 파라핀 블록으로 제조한 뒤 H&E(Hematoxylin & Eosin) 염색을 하여 관찰한다.(8) Histopathological examination: All organs whose weights have been measured are made into paraffin blocks and then stained with H&E (Hematoxylin & Eosin) for observation.
3.2.4 실험 디자인 및 군 구성3.2.4 Experimental design and group composition
실험 디자인experimental design
밀웜 분말 안전성을 확인하기 위해 체외(in vitro) 및 체내(in vivo) 실험을 계획하였다. In vitro and in vivo experiments were planned to confirm the safety of mealworm powder.
체외(in vitro) 단계에서 스티로폼을 먹이지 않은 밀웜 (w/o sty)과 먹인 밀웜 분말 (w/ sty) 처리시의 세포 증식률을 비교하였다. In the in vitro stage, the cell proliferation rate was compared between mealworms (w/o sty) that were not fed Styrofoam and those treated with mealworm powder (w/sty) that were fed Styrofoam.
체내(in vivo)단계에서 스티로폼을 먹이지 않은 밀웜과 먹인 밀웜 분말을 5주간 매일 경구 투여하였다. In the in vivo stage, mealworms not fed Styrofoam and mealworm powder fed were orally administered daily for 5 weeks.
투여 용량은 가장 최근에 측정한 사료 섭취량의 %로 선정하였다. 5주 경과 후 부검하여 검체를 채취 후 분석하였다.The administered dose was selected as a percentage of the most recently measured feed intake. After 5 weeks, an autopsy was performed and samples were collected and analyzed.
동물 실험군 및 투여용량 설정(실험군은 전체 5개군으로 설정하고, 군당 5마리로 설정하였다.)Animal test group and administration dose settings (the test group was set to 5 groups in total, with 5 animals per group.)
4. 실험 내용4. Experiment details
4.1 밀웜으로부터 추출물 제조4.1 Extract preparation from mealworms
채집된 밀웜 분말과 70% 에틸알코올(ethyl alcohol)을 3:7 비율로 3일동안 유효성분을 침출한 후 이후 회전 진공 농축기(EYELA N-1000)을 이용하여 45-50℃에서 하루 동안 감압 농축하여 농축된 샘플은 디메틸 술폭시드(dimethylsulfoxide) (DMSO)를 이용하여 최종 물질로 제조하였다.The active ingredients were leached with collected mealworm powder and 70% ethyl alcohol at a ratio of 3:7 for 3 days, then concentrated under reduced pressure for one day at 45-50°C using a rotary vacuum concentrator (EYELA N-1000). The concentrated sample was prepared into the final material using dimethylsulfoxide (DMSO).
4.2 세포실험4.2 Cell experiment
4.2.1 물질의 세포실험 적용 방법 설정4.2.1 Setting up the cell experiment application method of the material
물질을 녹일 수 있는 용매 선정한 뒤, 배지와 혼합할 시 이물질 생성을 확인하여, 만약 이물질 형성이 관찰 된다면 추후 세포실험을 위한 멸균 방법을 선정하였다.After selecting a solvent that can dissolve the substance, the formation of foreign substances was checked when mixed with the medium. If foreign substances were observed, a sterilization method for future cell experiments was selected.
4.2.2 양성 대조군 (17-βestradiol) 측정4.2.2 Positive control (17-βestradiol) measurement
에스트라디올(estradiol) 처리 후 MCF-7 생존율에 영향을 미치는 농도를 추후 세포 실험의 양성 대조군으로 적용하였다.The concentration affecting MCF-7 survival rate after estradiol treatment was applied as a positive control for subsequent cell experiments.
4.2.3 밀웜 분말처리시 MCF-7의 증식효과 확인4.2.3 Confirmation of proliferation effect of MCF-7 when treated with mealworm powder
스티로폼을 먹이지 않은 밀웜(w/o sty) 분말과 스티로폼을 먹인 밀웜(w/ sty) 분말을 MCF-7 세포에 처리했을 때 세포 생존율에 미치는 영향을 확인하였다.The effect on cell viability was confirmed when MCF-7 cells were treated with mealworm (w/o sty) powder not fed Styrofoam and mealworm (w/ sty) powder fed with Styrofoam.
4.3 동물실험4.3 Animal testing
4.3.1 주차별 체중 측정4.3.1 Weekly weight measurement
실험물질을 쥐(rat)에게 매일 경구 투여하며 주차별 2회씩 체중, 사료 섭취량, 음수량을 변화를 측정하여 실험물질투여에 의한 독성반응을 평가 하였다. 일반증상 관찰은 모든 동물에 대하여 1일 1회 관찰하였고, 1일 2회 사말 동물의 유무를 확인하였다.The test substance was orally administered to rats every day, and changes in body weight, food intake, and water amount were measured twice a week to evaluate the toxic response caused by the test substance administration. General symptoms were observed for all animals once a day, and the presence or absence of dead animals was checked twice a day.
4.3.2 장기 무게 측정4.3.2 Organ weight measurement
5주간 매일 실험물질을 쥐(rat)에게 경구 투여한 뒤 마지막 날 부검을 통해 신장(좌우), 비장, 심장, 부신(좌우), 정소(좌우), 폐, 흉선 등의 체중에 대한 절대장기 중량 및 상대장기 중량을 측정하였다After oral administration of experimental substances to rats every day for 5 weeks, an autopsy was performed on the last day to determine the absolute organ weight of kidneys (left and right), spleen, heart, adrenal glands (left and right), testes (left and right), lungs, and thymus. and relative organ weights were measured.
4.3.3 병리조직검사4.3.3 Histopathological examination
장기중량 측정이 끝난 모든 장기를 10% 중성 포르말린 액에 고정시키고 2주간 이상의 충분한 고정을 거친 모든 장기조직은 파라핀 포매기(SAKURA, Tissue-Tek VIP, vaccum infiltration Processor)에 포매하여 마이크로톰(Microm, HM340E)으로 2-3μm절편을 만들어 헤마톡실린과 에오신(Hematoxylin & Eosin) 염색을 하여 관찰하여 독성 여부를 확인하였다.All organs whose organ weights were measured were fixed in 10% neutral formalin solution, and all organ tissues that had been sufficiently fixed for more than 2 weeks were embedded in a paraffin embedder (SAKURA, Tissue-Tek VIP, vaccum infiltration processor) and microtome (Microm, HM340E). ), 2-3μm sections were made, stained with Hematoxylin & Eosin, and observed to check for toxicity.
4.3.4 혈액학적 및 혈청 생화학적 검사4.3.4 Hematological and serum biochemical tests
일반 혈액학적 검사는 적혈구수(RBC), 총백혈구수(WBC), 헤모글로빈(hemoglobin), 원심분리기(hematocrit), 평균적혈구용적 (MCV), 평균(적)혈구헤모글로빈 량(MCH), 평균(적)혈구헤모글로빈 농도(MCHC), 혈소판(platelet), 임파구(lymphocyte), 호중구(neutrophil), 혈액응고 시간(Prothrombin time(PT), Partial thromboplastin time(PTT) 등을 검사하였다.General hematological tests include red blood cell count (RBC), total white blood cell count (WBC), hemoglobin, hematocrit, mean corpuscular volume (MCV), mean (red) hemoglobin (MCH), and average (red) hemoglobin. ) Blood hemoglobin concentration (MCHC), platelets, lymphocytes, neutrophils, blood coagulation time (Prothrombin time (PT), Partial thromboplastin time (PTT), etc.) were tested.
혈청 생화학적 검사는 채취한 혈액의 일부를 실온에 30분간 방치하여 응고후 원심분리(3,000rpm, 30min)하여 얻은 혈청에 대해서 알라닌아미노전달효소 (alanine transaminase(ALT)), 아스파르테이트아미노전달효소 (aspartate transaminase(AST)), 알칼리 포스파타아제 (alkaline phosphatase(ALP)), 알부민(albumin), 총빌리루빈(total bilirubin), 혈앵요소질소(BUN), 총콜레스톨(total cholesterol), 크레아티닌(creatinine), 포도당(glucose), 총단백질량(total protein), 혈중지방(triglyceride), 칼슘(Ca) 등을 측정하였다.For the serum biochemical test, a portion of the collected blood was left at room temperature for 30 minutes, coagulated, and then centrifuged (3,000 rpm, 30 min). The serum obtained was tested for alanine transaminase (ALT) and aspartate aminotransferase. (aspartate transaminase (AST)), alkaline phosphatase (ALP), albumin, total bilirubin, blood urea nitrogen (BUN), total cholesterol, creatinine , glucose, total protein, blood fat (triglyceride), calcium (Ca), etc. were measured.
4.4 통계처리4.4 Statistical processing
실험에서 얻어진 결과는 mean ± standard deviation (S.D)으로 나타내고 아래의 방법으로 통계 분석을 실시하였다. 일원분산분석(One-way analysis of variance (ANOVA))를 실시하여 유의성(유의성 수준: ??0.05)을 관찰하였고 F-test를 실시하여 분산 검정한 결과 등분산 (유의수준: 0.05)이 인정되면 T-test 검정(유의수준: 0.05)을 실시하여 P<0.05는 통계적으로 유의한 차이를 나타내는 것으로 판단하였다.The results obtained from the experiment were expressed as mean ± standard deviation (S.D) and statistical analysis was performed using the method below. One-way analysis of variance (ANOVA) was performed to observe significance (significance level: ??0.05), and F-test was performed to test variance. If equal variance (significance level: 0.05) was recognized, A T-test (significance level: 0.05) was performed and P<0.05 was judged to indicate a statistically significant difference.
5. 연구결과5. Research results
5.1 밀웜으로부터 추출물 제조5.1 Preparation of extract from mealworms
채집된 밀웜 분말과 70% ethyl alchol을 3:7 비율로 상온에서 3일동안 반응시켜 유효성분을 침출하였다.The active ingredients were leached out by reacting the collected mealworm powder with 70% ethyl alcohol in a 3:7 ratio at room temperature for 3 days.
침출된 샘플은 회전진공농축기(EYELA N-1000, EYELA, Tokyo, Japan)를 이 용하여 45-50°C에서 감압 농축시켰다.The leached sample was concentrated under reduced pressure at 45-50°C using a rotary vacuum concentrator (EYELA N-1000, EYELA, Tokyo, Japan).
농축된 샘플을 dimethylsulfoxide (DMSO)를 이용하여 최종 물질을 제조하였다.The final material was prepared from the concentrated sample using dimethylsulfoxide (DMSO).
최종 물질은 처치농도에 따라 단계별로 희석하였다.The final material was diluted step by step according to the treatment concentration.
5.2 물질의 세포실험 적용방법 결과5.2 Result of cell test application method of material
용매는 물질을 녹일 수 있는 DMSO 사용하였다The solvent used was DMSO, which can dissolve the substance.
배지와 혼합시 멸균 유무와 상관없이 이물질이 발견 되었다.When mixed with medium, foreign substances were found regardless of sterilization.
필터 사용 후 배지와 혼합시 이물질이 발견되지 않았다.No foreign substances were found when mixed with the medium after using the filter.
필터 사용 후 세포에 적용시 이물질 및 오염이 발견되지 않았다.No foreign substances or contamination were found when applied to cells after using the filter.
5.3 세포 실험5.3 Cell experiments
5.3.1 양성 대조군 (17-βestradiol) 측정5.3.1 Positive control (17-βestradiol) measurement
양성 대조군 (E2) 처리 시 10-9M이상의 농도부터 증식률 증가하였다.When treated with the positive control (E2), the proliferation rate increased from concentrations above 10 -9 M.
E2의 농도는 대조군과 비교하여 세포의 증식률에 대해 가장 큰 증가를 보였던 10-8M 농도로 선정하였다.The concentration of E2 was selected at 10 -8 M, which showed the greatest increase in cell proliferation rate compared to the control group.
5.3.2 밀웜 분말처리시 MCF-7의 증식효과 확인5.3.2 Confirmation of proliferation effect of MCF-7 when treated with mealworm powder
에스트로겐(Estrogen) 의존성 유방암 세포에 E2를 양성대조군으로 설정한 뒤 스티로폼을 먹인 밀웜 추출물을 처리하여 세포 증식률 평가하였다.E2 was set as a positive control for estrogen-dependent breast cancer cells, and then treated with mealworm extract fed with Styrofoam to evaluate the cell proliferation rate.
밀웜 추출물은 필터 처리하여 세포에 적용하였으며, DMSO에 녹일 수 있는 최대량을 고농도로 선정하였다.The mealworm extract was filtered and applied to cells, and the maximum amount that could be dissolved in DMSO was selected as the high concentration.
E2 처리하였을 때 세포의 증식률이 증가하였으며, 이를 통해 실험의 유효성을 확인하였다.When treated with E2, the proliferation rate of cells increased, confirming the effectiveness of the experiment.
스티로폼 유무에 따른 두 종류의 밀웜 추출물을 처리하였을 때, 처치한 두 군 모두에서 대조군과 비교하여 유의적인 증감은 보이지 않았다.When two types of mealworm extracts were treated with or without Styrofoam, no significant increase or decrease was seen in both groups compared to the control group.
스티로폼 유무에 따른 두 군간의 증식률 차이는 관찰되지 않았다.No difference in proliferation rate was observed between the two groups with or without Styrofoam.
5.4 동물실험5.4 Animal testing
5.4.1 주차별 체중 측정 5.4.1 Weekly weight measurement
실험 개시 후, 주 2회와 부검 직전에 모든 동물의 체중, 사료 섭취량, 음수량을 측정하였다.After the start of the experiment, the body weight, food intake, and water volume of all animals were measured twice a week and immediately before necropsy.
임상 증상을 관찰하였을 때, 모든 군에서 이상 징후를 보이거나 사망한 개체가 없음을 확인하였다.When observing clinical symptoms, it was confirmed that no individual showed abnormal signs or died in any group.
멸균 증류수를 투여한 대조군과 비교하여 밀웜 분말을 먹인 군에서 체중의 감소가 관찰 되었다. A decrease in body weight was observed in the group fed mealworm powder compared to the control group administered sterilized distilled water.
일반 밀웜군(w/o sty 10%)과 비교하여 스티로폼을 먹은 밀웜군(w/ sty 10%)은 유의적인 체중감소를 보이지 않았다.Compared to the regular mealworm group (w/o sty 10%), the mealworm group that ate Styrofoam (w/sty 10%) did not show significant weight loss.
5.4.2 주차별 사료 섭취량 측정5.4.2 Weekly feed intake measurement
실험 기간 동안, 대조군은 4일과 10일을 제외하고 밀웜 분말 투여군과 비교하여 높은 사료 섭취량을 보였다.During the experiment, the control group showed higher feed intake compared to the mealworm powder-treated group except for days 4 and 10.
투여 후 14일 차에 모든 군에서 사료 섭취량의 감소가 관찰되었으나, 이후 다시 증가하는 경향을 나타냈다.A decrease in feed intake was observed in all groups on the 14th day after administration, but it tended to increase again thereafter.
투여 31일차에 대조군과 비교하여 w/sty 10%군에서 유의적인 사료 섭취량 감소가 나타났으나 이후 다시 증가되는 것이 관찰되었다.On the 31st day of administration, a significant decrease in feed intake was observed in the w/sty 10% group compared to the control group, but an increase was observed again thereafter.
일반밀웜군(w/o sty 10%)과 스티로폼을 먹인 밀웜군(w/ sty 10%)과의 유의적인 사료 섭취량 차이는 보이지 않았다.There was no significant difference in feed intake between the general mealworm group (w/o sty 10%) and the Styrofoam-fed mealworm group (w/sty 10%).
5.4.3 주차별 음수량 측정5.4.3 Measurement of drinking water volume per week
투여 후 17일차에 모든 군에서 음수량의 감소가 관찰되었으나, 이후 다시 증가하는 경향을 나타냈다.A decrease in drinking water was observed in all groups on the 17th day after administration, but it tended to increase again thereafter.
17일, 28일, 31일, 35일에 w/ sty 5%군은 다른 군과 비교하여 낮은 음수량을 보였다.On days 17, 28, 31, and 35, the w/sty 5% group showed lower drinking water volume compared to other groups.
투여 후 31일차에 대조군과 비교하여 w/ sty 5, 15%군에서 음수량이 유의적으로 감소하였지만, 이후 다시 회복되었다.On the 31st day after administration, the amount of drinking water significantly decreased in the w/sty 5, 15% group compared to the control group, but recovered again later.
w/o sty 10%군과 w/ sty 10%군과의 유의적인 음수량 차이는 보이지 않았다.There was no significant difference in water volume between the w/o sty 10% group and the w/ sty 10% group.
5.5 장기 무게 측정5.5 Organ weight measurement
투여 35일차에 실험을 종료한 후 부검을 진행하여 절대장기중량 및 상대장기중량을 측정하였다.After completing the experiment on the 35th day of administration, an autopsy was performed and absolute and relative organ weights were measured.
심장(Heart)과 가슴샘(thymus)을 제외한 장기들의 경우 대조군과 비교하여 밀웜투여군에서 절대장기중량이 감소한 것으로 나타났으나, 이를 상대장기중량으로 확인한 결과, 큰 차이는 나타나지 않았다.In the case of organs excluding the heart and thymus, the absolute organ weight was found to be reduced in the mealworm-administered group compared to the control group, but when this was confirmed by relative organ weight, no significant difference was found.
심장(Heart)과 가슴샘(thymus)의 경우 대조군과 비교하여 밀웜 투여군에서는 절대장기 중량뿐만 아니라 상대장기중량 또한 증가하는 경향을 나타냈다.In the case of the heart and thymus, not only the absolute organ weight but also the relative organ weight tended to increase in the mealworm-administered group compared to the control group.
가슴샘(Thymus)의 경우 w/o sty 10%군과 비교하여 w/ sty 5, 10, 15%군에서 절대장기중량과 상대장기중량 모두 증가하는 경향을 보였다.In the case of the thymus, both absolute and relative organ weights tended to increase in the w/sty 5, 10, and 15% groups compared to the w/o sty 10% group.
폐(Lung)와 비장(spleen)의 경우 w/o sty 10%군은 절대장기중량과 상대장기중량 모두 가장 낮게 나타냈다.In the case of lung and spleen, the w/o sty 10% group showed the lowest absolute and relative organ weights.
정소(Testes)의 경우 절대장기중량에서 대조군과 비교하여 밀웜 분말을 투여한 군에서 감소하는 경향을 보였지만 상대장기중량의 경우 차이를 보이지 않았다.In the case of testes, absolute organ weight tended to decrease in the group administered mealworm powder compared to the control group, but there was no difference in relative organ weight.
W/o sty 10%군과 w/ sty 10%군을 비교하였을 때 절대장기중량과 상대장기중량 모두 유의적인 차이는 관찰되지 않았다.When comparing the W/o sty 10% group and the w/ sty 10% group, no significant differences were observed in both absolute and relative organ weights.
5.6 병리조직검사5.6 Histopathological examination
헤마톡실린(Hematoxylin)은 리보솜, 세포핵과 같은 호염기성 물질에 어두운 푸른색으로 염색된다.Hematoxylin stains basophilic substances such as ribosomes and cell nuclei in dark blue.
에오신(Eosin)은 세포질, 세포막과 같은 호산성 물질에 붉은색으로 염색된다.Eosin stains eosinophilic substances such as cytoplasm and cell membranes red.
헤마톡실린과 에오신(Hematoxylin and Eosin(H&E)) 염색을 통해 간과 신장의 세포와 조직의 변화를 확인하였다Changes in cells and tissues of the liver and kidney were confirmed through hematoxylin and eosin (H&E) staining.
대조군과 비교하여 밀웜 분말을 투여한 군에서 사구체 크기의 확대 혹은 축소, 간에서의 출혈 등과 같은 이상유무는 발견되지 않았다.Compared to the control group, no abnormalities such as enlargement or reduction of glomerular size or liver hemorrhage were found in the group administered mealworm powder.
W/o sty 10%군과 w/ sty 10%군을 비교하였을 때 간과 신장 모두 유의적인 차이는 관찰되지 않았다.When comparing the w/o sty 10% group and the w/ sty 10% group, no significant differences were observed in both liver and kidney.
5.7 혈액학적 및 혈청 생화학적 검사5.7 Hematological and serum biochemical tests
5.7.1 혈액학적 검사5.7.1 Hematological tests
w/ sty 5%군과 w/ sty 15%군은 대조군과 비교하여 WBC가 높은 경향은 보였지만, 유의적인 증가는 없었다.The w/ sty 5% group and the w/ sty 15% group showed a tendency for WBC to be higher compared to the control group, but there was no significant increase.
W/o sty 10%군과 비교하여 w/ sty 10%군에서 호중구(neutophils)와 림프구(lymphocyte)를 제외한 모든 항목에서 유의적인 차이는 나타나지 않았다.Compared to the w/o sty 10% group, there was no significant difference in all items except neutrophils and lymphocytes in the w/ sty 10% group.
산호성백혈구(Eosinophils)의 경우 w/ sty 5%군에서 가장 낮은 경향을 보였다.Eosinophils tended to be lowest in the w/sty 5% group.
호염기성세포(Basophils)의 경우 밀웜 투여군은 대조군과 비교하여 감소하는 경향이 보였지만 유의적인 차이는 없었다.In the case of basophils, the mealworm-treated group showed a tendency to decrease compared to the control group, but there was no significant difference.
혈소판(Platelet)의 경우 w/o sty 10%군에서 가장 낮게 측정되었으며, 이와 반대로 w/ sty 15%군에서 가장 높게 측정되었다.In the case of platelets, the lowest measurements were made in the w/o sty 10% group, and conversely, the highest measurements were made in the w/ sty 15% group.
w/o sty 10% 군과 w/ sty 10%군을 비교하였을 때, 혈액학적으로 유의적인 차이를 나타내지 않았다.When comparing the w/o sty 10% group and the w/ sty 10% group, there was no significant hematological difference.
삭제delete
5.7.2 혈청 생화학적 검사5.7.2 Serum biochemical tests
총빌리루빈(Total bilirubin)의 경우 대조군과 w/ sty 5, 10%군은 측정범위 이하의 값을 나타냈다.In the case of total bilirubin, the control group and w/ sty 5, 10% group showed values below the measurement range.
간 수치의 지표로 많이 사용되는 아스파르트산아미노기전달효소 (aspartate aminotransferase), 알라닌아미노기전달효소 (alanine aminotransferase), 알칼리 포스파타아제(alkaline phosphatase)의 경우 대조군과 비교하여 모두 감소하는 경향을 나타냈지만 유의적인 차이를 보이지는 않았다.Aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase, which are widely used as indicators of liver levels, all showed a tendency to decrease compared to the control group, but there was a significant decrease. There was no difference.
대조군과 비교하여 w/ sty 10%와 w/ sty 15%군에서 나트륨(Na) 항목은 유의적으로 증가하였다.Compared to the control group, sodium (Na) significantly increased in the w/sty 10% and w/sty 15% groups.
w/o sty 10% 군과 w/ sty 10%군을 비교하였을 때, 혈청 생화학적으로 유의적인 차이를 나타내지 않았다.When comparing the w/o sty 10% group and the w/ sty 10% group, there was no significant difference in serum biochemistry.
6. 결론 및 고찰6. Conclusion and Discussion
본 실험은 에스트로겐(estrogen) 의존성 세포와 수컷 쥐(SD rat)에 스티로폼 급여 밀웜 분말 처치에 따른 독성 평가를 목적으로 한다. The purpose of this experiment is to evaluate the toxicity of estrogen-dependent cells and male rats (SD rats) treated with mealworm powder fed to Styrofoam.
먼저, 밀웜 분말 추출물을 이용하여 MCF-7 세포의 증식 여부 확인하였으며, 쥐(SD rat)에 5주간 밀웜 분말을 경구 투여하여 안전성을 평가하였다.First, the proliferation of MCF-7 cells was confirmed using mealworm powder extract, and the safety was evaluated by orally administering mealworm powder to SD rats for 5 weeks.
세포 실험은 에스트로겐(estrogen) 유도 시험에 주로 사용되는 17-βestradiol (E2)을 양성 대조군으로 선정하였다. For cell experiments, 17-βestradiol (E2), which is mainly used in estrogen induction tests, was selected as a positive control.
밀웜 분말 추출물은 스티로폼을 먹이지 않은 군 (w/o sty)과 스티로폼을 먹인 밀웜 분말군 (w/ sty)에서 추출하였으며, 추출물의 농도는 용매인 DMSO에 녹일 수 있는 최대 용량인 250mg/ml을 고농도로 선정한 뒤 세포 실험을 진행하였다. The mealworm powder extract was extracted from the group not fed Styrofoam (w/o sty) and the mealworm powder group fed Styrofoam (w/sty), and the concentration of the extract was 250 mg/ml, which is the maximum capacity that can be dissolved in the solvent DMSO. After selection, cell experiments were conducted.
그 결과 대조군과 비교하여 E2를 처치한 양성대조군에서 세포의 증식률이 증가하는 경향을 보였지만, 처치군에서는 큰 차이를 보이지 않았다. As a result, compared to the control group, the cell proliferation rate tended to increase in the positive control group treated with E2, but there was no significant difference in the treatment group.
또한, w/o sty과 w/ sty 간의 증식률 차이 또한 관찰되지 않았다. 이러한 결과는 스티로폼을 먹인 밀웜이 세포에 대하여 독성은 보이지 않았으며, 더 나아가 estrogen 유도 반응을 보이지 않은 것으로 사료된다.Additionally, no difference in proliferation rate was observed between w/o sty and w/ sty. These results suggest that the mealworms fed Styrofoam did not show any toxicity to the cells, and furthermore, did not show an estrogen-inducing response.
동물시험은 총 5개의 실험군으로 대조군 (멸균 생리식염수), 일반 밀웜 분말 투여군 (w/o sty 10%), 스티로폼을 먹인 밀웜 분말 투여 저농도 (w/ sty 5%), 중농도 (w/ sty 10%), 고농도 (w/ sty 15%)로 설정하였고, 5주간 매일 경구투여를 진행하였다. 밀웜 분말의 농도는 최근 측정한 사료 섭취량의 5%, 10%, 15%로 선정하였다. The animal test consisted of a total of 5 experimental groups: a control group (sterilized saline solution), a group administered regular mealworm powder (w/o sty 10%), a low concentration group administered mealworm powder fed Styrofoam (w/ sty 5%), and a medium concentration group (w/ sty 10). %), was set at a high concentration (w/sty 15%), and oral administration was conducted daily for 5 weeks. The concentration of mealworm powder was selected at 5%, 10%, and 15% of the recently measured feed intake.
투여 후 매일 일반증상 관찰을 진행하였으며, 주 2회 모든 쥐(rat)에 대해 체중, 사료 섭취량, 음수량을 측정하였으며, 5주차에 부검을 통해 rat의 장기 중량을 측정하고 헤마톡실린과 에오신(Hematoxylin and Eosin(H&E)) 염색을 통해 조직학적 분석을 진행하며, 부검 진행 중 복대동맥에서 채혈한 혈액을 통해 혈액학적 및 혈청 생화학적 검사를 진행하였다.After administration, general symptoms were observed every day, and body weight, food intake, and drinking amount were measured for all rats twice a week. At the 5th week, the rat's organ weight was measured through an autopsy, and hematoxylin and eosin were administered. Histological analysis was performed through (and Eosin (H&E)) staining, and hematological and serum biochemical tests were performed using blood collected from the abdominal aorta during the autopsy.
시험 기간 중 사망한 동물은 없었고 특이한 임상 증상을 보이는 동물도 없었다. No animals died during the test period and no animals showed unusual clinical symptoms.
체중 변화의 경우 w/o sty 10%군과 w/ sty 10%군간의 차이는 관찰되지 않았다. 하지만 대조군과 비교하여 밀웜 분말 투여군 모두에서 감소하는 경향을 보였지만 유의적인 차이를 보이지 않았다. In case of weight change, no difference was observed between the w/o sty 10% group and the w/ sty 10% group. However, compared to the control group, there was a tendency to decrease in all groups administered mealworm powder, but there was no significant difference.
이러한 결과는 밀웜 분말을 투여하는 과정 중 rat를 보정하는 시간이 오래 걸린 것에 반해, 멸균 생리식염수를 먹인 대조군은 짧은 보정 시간으로 인해 낮은 스트레스를 받은 것으로 체중의 차이가 생긴 것으로 판단된다. These results suggest that the difference in body weight occurred because it took a long time to calibrate the rats during the process of administering mealworm powder, whereas the control group fed sterilized saline solution experienced low stress due to the short calibration time.
사료 섭취량의 경우 실험기간 동안 밀웜 분말 투여군에서 대조군에 비하여 평균 소모량이 적은 것으로 나타났으며, 14일차에는 실험군 모두에서 감소하는 경향이 나타났으나, 이후 점차 증가하는 경향을 보였다. 14일 이전까지 사료 섭취량이 일정한 경향을 보이지 않은 것으로 보아, 이는 투여에 적응하는 기간으로 인한 것으로 생각된다. In the case of feed intake, the average consumption was found to be lower in the mealworm powder administration group than the control group during the experimental period. It tended to decrease in all experimental groups on the 14th day, but then tended to gradually increase. Since feed intake did not show a consistent trend before 14 days, this is thought to be due to the period of adaptation to administration.
음수량의 경우 w/o 10%군과 w/ 10%군간의 유의적인 차이는 관찰되지 않았다. 조직병리학적 변화를 관찰하였을 때, 대조군과 비교하여 밀웜 분말을 투여한 군에서 간과 신장의 이상유무는 발견되지 않았다. In case of drinking water volume, no significant difference was observed between the w/o 10% group and the w/ 10% group. When observing histopathological changes, no liver or kidney abnormalities were found in the group administered mealworm powder compared to the control group.
더욱이 w/o sty 10%군과 w/ sty 10%군을 비교하였을 때 간과 신장 모두 유의적인 차이는 관찰되지 않았다. Moreover, when comparing the w/o sty 10% group and the w/ sty 10% group, no significant differences were observed in both liver and kidney.
밀웜 투여 5주차 부검 후 간 (liver), 신장 (kidney), 부신 (adrenal gland), 심장 (heart), 가슴샘 (thymus), 정소 (testes), 폐 (lung), 비장 (spleen)을 적출하여 절대장기중량 (g) 과 상대장기중량 (%)를 측정하였다. After an autopsy at the 5th week of mealworm administration, the liver, kidneys, adrenal glands, heart, thymus, testes, lungs, and spleen were removed. Organ weight (g) and relative organ weight (%) were measured.
밀웜 투여군을 대조군과 비교하였을 때 심장과 가슴샘을 제외한 장기들은 절대장기중량이 감소하는 경향을 보였지만 이를 상대장기줄량으로 보았을때는 큰 차이를 보이지 않았다. When comparing the mealworm-administered group with the control group, the absolute organ weights of organs except the heart and thymus tended to decrease, but when viewed in terms of relative organ mass, there was no significant difference.
이러한 결과는 rat의 체중에 따른 것으로 판단된다. w/o sty 10%군과 w/ sty 10%군의 장기들을 비교하였을 때 가슴샘을 제외한 장기들은 큰 차이를 보이지 않았다. These results are believed to be dependent on the rat's body weight. When comparing the organs of the w/o sty 10% group and the w/ sty 10% group, there was no significant difference in organs except the thymus.
가슴샘의 경우 w/ sty 10%군이 두 장기중량 모두 증가하는 경향을 보였지만, 유의적인 차이를 보이지는 않았다. In the case of the thymus, both organ weights tended to increase in the w/sty 10% group, but there was no significant difference.
또한 정소의 경우 대조군과 비교하여 밀웜 분말을 투여한 군에서 절대장기중량은 감소하는 경향을 보였지만, 이를 상대장기중량으로 측정하였을 때 유의적인 차이는 관찰되지 않았다. In addition, in the case of testes, absolute organ weight tended to decrease in the group administered mealworm powder compared to the control group, but no significant difference was observed when measured by relative organ weight.
이러한 결과를 종합해볼 때, 스티로폼 급여한 밀웜을 투여한 생체에서의 독성를 일으키지 않은 것으로 판단된다.Considering these results, it is judged that mealworms fed with Styrofoam did not cause toxicity in living organisms.
부검 시 진행한 복대동맥에서 채혈한 혈액을 혈액학적 검사 및 혈청 생화학적 검사를 통해 혈액내 성분을 검사 하였다. Blood collected from the abdominal aorta during autopsy was tested for blood components through hematological and serum biochemical tests.
호중구(Neutrophils)의 경우 w/o sty 10%군과 w/ sty 10%을 비교하였을 때 증가하는 경향을 보였지만, 이는 정상범위 (6.2-26.7%)로 질병에 의한 것이 아닌 개체차이에 의한 것으로 생각된다. In the case of neutrophils, there was a tendency to increase when comparing the w/o sty 10% group with the w/ sty 10% group, but this was within the normal range (6.2-26.7%) and is thought to be due to individual differences rather than disease. do.
이와 마찬가지로 림프구(lymphocytes)의 경우 w/o sty 10%군과 w/ sty 10%을 비교하였을 때 감소하는 경향은 보였지만, 이는 정상범위 (66.6-90.3%)내 위치하고 있으므로 스티로폼의 유무에 의한 차이는 아닌 것으로 판단된다.Similarly, in the case of lymphocytes, a tendency to decrease was seen when comparing the w/o sty 10% group with the w/ sty 10% group, but since this was within the normal range (66.6-90.3%), the difference due to the presence or absence of Styrofoam was It is judged not to be so.
호염기성세포(Basophils)의 경우 대조군과 비교하여 밀웜 투여군에서 감소하는 경향을 보였지만 유의적인 차이를 보이지는 않았다. Basophils tended to decrease in the mealworm-treated group compared to the control group, but there was no significant difference.
또한 혈액에서 채취한 혈청을 통해 생화학적 검사를 진행하였다. 생화학적 검사를 통해 혈청을 검사하였다. Additionally, biochemical tests were performed using serum collected from blood. Serum was tested using biochemical tests.
그 결과 간 수치의 지표로 많이 사용되는 아스파르트산아미노기전달효소 (aspartate aminotransferase), 알라닌아미노기전달효소 (alanine aminotransferase), 알칼리 포스파타아제(alkaline phosphatase)의 경우 대조군과 비교하여 감소하는 경향을 나타냈다. As a result, aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase, which are widely used as indicators of liver levels, tended to decrease compared to the control group.
총빌리루빈(Total bilirubin)의 경우 대조군과, w/ sty 5%, 15%군은 측정범위 이하의 값을 나타냈다. 결과적으로, 혈청 검사에서는 w/o sty 10%군과 w/ sty 10%군 간의 유의적인 차이는 관찰되지 않았다.In the case of total bilirubin, the control group and the w/sty 5% and 15% groups showed values below the measurement range. As a result, no significant difference was observed between the w/o sty 10% group and the w/ sty 10% group in the serum test.
종합적으로, 본 실험 물질 (스티로폼 급여 밀웜 분말)을 에스트로겐(estrogen) 의존성 세포에 적용하였을 때 세포의 증식률을 증가시키지 않은 것으로 보아 에스트로겐(estrogen) 유도 반응을 보이지 않는 것으로 사료된다. Overall, when this experimental material (Styrofoam-fed mealworm powder) was applied to estrogen-dependent cells, it did not increase the proliferation rate of the cells, suggesting that it does not show an estrogen-inducing response.
더불어 동물실험을 진행한 결과, 대조군과 비교하여 밀웜 투여군 모두에서 체중의 감소가 나타났지만, w/o sty 10%군과 w/ sty 10%군을 비교하였을 때 유의적인 차이는 나타나지 않았다. In addition, as a result of animal testing, there was a decrease in body weight in both groups administered mealworms compared to the control group, but no significant difference was found when comparing the w/o sty 10% group and the w/ sty 10% group.
이러한 결과는 스티로폼 급여에 따른 영향보다 밀웜분말의 점도에 의한 보정 시간의 증가에 따른 스트레스로 인한 것으로 사료된다. These results are believed to be due to stress caused by an increase in correction time due to the viscosity of meal worm powder rather than the effect of feeding Styrofoam.
또한, w/ sty 10%군은 w/o sty 10%군과 비교하여. 폐와 비장을 제외한 장기들의 절대장기중량이 감소한 것으로 나타났으나, 이를 상대장기중량으로 계산한 결과 두 군의 차이는 관찰되지 않았다. Additionally, the w/ sty 10% group compared to the w/o sty 10% group. The absolute organ weights of organs except the lungs and spleen were found to be reduced, but when this was calculated as relative organ weights, no differences were observed between the two groups.
또한 간과 신장을 H&E 염색을 통해 비교하였을 때 w/ sty 10%군과 w/o sty 10%군 간의 차이는 발견되지 않았다. 혈액학적, 혈청 생화학적 검사에서 w/o sty 10%군과 w/ sty 10%군의 차이는 관찰 되었지만, 정상범위 내의 수치를 보였다. Additionally, when comparing the liver and kidneys through H&E staining, no difference was found between the w/ sty 10% group and the w/o sty 10% group. In hematological and serum biochemical tests, differences were observed between the w/o sty 10% group and the w/ sty 10% group, but the values were within the normal range.
따라서, 세포 실험과 동물 실험을 통해 스티로폼을 급여한 밀웜 분말 가루의 안전성을 확인한 결과, 세포에 대하여 에스트로겐(estrogen)의 영향은 없는 것으로 사료되며, 수컷 쥐(rat)에 대하여 독성을 나타내지 않는 것으로 판단된다.Therefore, as a result of confirming the safety of mealworm powder fed with Styrofoam through cell and animal experiments, it is believed that there is no effect of estrogen on cells and it is judged not to be toxic to male rats. do.
이상과 같이 본 발명의 스티로폼(EPS) 폐기물을 재활용하는 방법으로 사육된 밀웜은 독성이 없어서 식량으로 활용할 수 있다는 것이 실험을 통해서 확인이 되었다.As described above, it was confirmed through experiments that mealworms raised by the method of recycling Styrofoam (EPS) waste of the present invention are non-toxic and can be used as food.
이상에서 본 발명의 실시예에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고 다음의 청구범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리범위에 속하는 것이다.Although the embodiments of the present invention have been described in detail above, the scope of the present invention is not limited thereto, and various modifications and improvements made by those skilled in the art using the basic concept of the present invention defined in the following claims are also possible. It falls within the scope of rights.
100: 밀웜사육장치 10: 브리딩모듈
11: 산란모듈 12-1~12-4: 생육모듈
20-1~20-10: 피딩모듈 30: 안정화모듈 100: Mealworm breeding device 10: Breeding module
11: Spawning module 12-1~12-4: Growth module
20-1~20-10: Feeding module 30: Stabilization module
Claims (2)
상기 산란단계(S100)에서 산란된 알을 성충거저리의 배설물과 함께 수거하여 4구역으로 구성된 생육모듈(12-1, 12-2, 12-3, 12-4)의 첫번째 생육모듈(12-1)로 이송(쉬프트)시켜 밀기울과 배합하는 배합단계(S200);
상기 배합단계(S200)에서 1주일 동안 부화를 시키고 생육을 시킨 후 두번째 생육모듈(12-2)로 이송(쉬프트) 시키고, 상기 두번째 생육모듈(12-2)에서 1주일 동안 생육 후 세번째 생육모듈(12-3)로 이송시키고, 상기 세번째 생육모듈(12-3)에서 1주일 동안 생육을 시키고, 네번째 생육모듈(12-4)로 순차적으로 이송을 시키는 생육단계(S300);
상기 생육단계(S300)에서 4주 동안 성장한 애벌레는 피딩모듈(20-1~20-10)로 순차적으로 이송이 되어 10주 동안 스티로폼 케이크(110)를 섭취하면서 원하는 크기만큼의 애벌레로 성장을 하게 되는 피딩단계(S400);
상기 피딩단계(S400)에서 10주 동안 피딩모듈에서 성장한 애벌레는 안정화모듈(30)로 이송되어 5일간 밀기울만 먹이면서 체내의 스치로폼을 완전히 없애고, 2일 동안은 절식을 시켜 밀원의 장을 비우도록 하는 안정화단계(S500); 및
상기 안정화단계(S500)를 거친 밀웜의 스티로폼 체내 잔유물 존재여부를 확인하기 위하여 초음파, 엑스레이 등을 이용하여 표본 혹은 전수 검사하여 밀웜의 체내에 스티로폼 잔유물이 있는지를 검사하여 잔유물이 존재할 경우 2일 동안 추가로 절식을 시켜 잔유물을 완전히 제거하는 검사단계(S600);를 포함하는 것을 특징으로 하는 스티로폼 폐기물을 이용한 밀웜 사육 방법.A spawning step (S100) in which adult mealworms are fed for one week to lay eggs in the spawning module 11 of the breeding module 10;
The eggs spawned in the spawning step (S100) are collected together with the excrement of adult mealworms and grown in the first growth module (12-1) of the growth modules (12-1, 12-2, 12-3, 12-4) composed of 4 zones. ) and mixing with wheat bran (S200);
After hatching and growing for one week in the mixing step (S200), they are transferred (shifted) to the second growth module (12-2), and grown for one week in the second growth module (12-2) and then transferred to the third growth module. A growth step (S300) of transferring to (12-3), growing for one week in the third growth module (12-3), and sequentially transferring to the fourth growth module (12-4);
The larvae that grew for 4 weeks in the growth stage (S300) are sequentially transferred to the feeding modules (20-1 to 20-10) and grow into larvae of the desired size while eating the Styrofoam cake (110) for 10 weeks. Feeding step (S400);
In the feeding step (S400), the larvae that grew in the feeding module for 10 weeks are transferred to the stabilization module (30) and fed only with wheat bran for 5 days to completely eliminate Styrofoam in the body, and are fasted for 2 days to empty the intestines of the wheat source. Stabilization step (S500); and
In order to check whether there is any Styrofoam residue in the body of the mealworm that has gone through the above stabilization step (S500), a sample or all samples are examined using ultrasound, A method of raising mealworms using Styrofoam waste, comprising an inspection step (S600) of completely removing residues by fasting.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220005225A KR102685908B1 (en) | 2022-01-13 | 2022-01-13 | Method for breeding millworm using styrofoam waste |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220005225A KR102685908B1 (en) | 2022-01-13 | 2022-01-13 | Method for breeding millworm using styrofoam waste |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230109356A KR20230109356A (en) | 2023-07-20 |
KR102685908B1 true KR102685908B1 (en) | 2024-07-17 |
Family
ID=87426322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220005225A KR102685908B1 (en) | 2022-01-13 | 2022-01-13 | Method for breeding millworm using styrofoam waste |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102685908B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107321759A (en) * | 2017-07-13 | 2017-11-07 | 同济大学 | A kind of method of the discarded membrane material of yellow meal worm degraded |
KR101958175B1 (en) | 2018-06-26 | 2019-03-18 | 주식회사 씨아이이에프 | Larva selecting system |
KR102193095B1 (en) * | 2020-07-23 | 2020-12-18 | 박지우 | Up-cycle circulation farming using surplus agricultural products and processed by-products |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3034623B1 (en) * | 2015-04-13 | 2017-04-14 | Ynsect | INSECT BREEDING METHOD |
KR20170109470A (en) | 2016-03-21 | 2017-09-29 | 조익형 | The Experimental teaching method use to mealworm cracker to Styrofoam |
EP3684174A2 (en) | 2017-09-18 | 2020-07-29 | Entomics Biosystems Limited | Insect larvae rearing |
KR102324532B1 (en) * | 2019-11-14 | 2021-11-11 | 농업회사법인 주식회사 동의보굼 | Roast Grain Powder Mixed Functional Edible Insect Powder and Manufacturing Method thereof |
-
2022
- 2022-01-13 KR KR1020220005225A patent/KR102685908B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107321759A (en) * | 2017-07-13 | 2017-11-07 | 同济大学 | A kind of method of the discarded membrane material of yellow meal worm degraded |
KR101958175B1 (en) | 2018-06-26 | 2019-03-18 | 주식회사 씨아이이에프 | Larva selecting system |
KR102193095B1 (en) * | 2020-07-23 | 2020-12-18 | 박지우 | Up-cycle circulation farming using surplus agricultural products and processed by-products |
Also Published As
Publication number | Publication date |
---|---|
KR20230109356A (en) | 2023-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Svoboda et al. | Biochemical profile of blood plasma of tench (Tinca tinca L.) during pre-and postspawning period | |
Ekeanyanwu et al. | Acute and subacute oral toxicity study on the flavonoid rich fraction of Monodora tenuifolia seed in albino rats | |
Shittu et al. | Toxicological Implications of Methanol Extract from Nigerian Bee Propolis On Some Selected Rat Tissues. | |
Dansereau et al. | Reproductive performance of two generations of female semidomesticated mink fed diets containing organic mercury contaminated freshwater fish | |
Michael | Toxicity effect of atrazine on histology, haematology and biochemical indices of Clarias gariepinus | |
Park et al. | The sterilization effect of methylene blue, formalin, and iodine on egg and adult stage of marine medaka, Oryzias dancena | |
KR102685908B1 (en) | Method for breeding millworm using styrofoam waste | |
Ileke et al. | Toxicological and histopathological effects of cheese wood, alstonia boonei de wild stem bark powder used as cowpea protectant against cowpea bruchid, callosobruchus maculatu (fab.)[coleoptera: Chrysomelidae] on albino rats | |
Şensoy | Investigation of the effect of Cadmium chloride applied during pregnancy on the morphological parameters of mouse offspring and the protective role of melatonin | |
KR100293764B1 (en) | Dioxin toxicity detoxifiers based on ginseng | |
Chivapat et al. | Chronic toxicity of Thunbergia laurifolia Lindl. extract | |
Aguirre et al. | Breeding, husbandry, veterinary care, and hematology of marsh rice rats (Oryzomys palustris), a small animal model for periodontitis | |
Kassarov | Are birds able to taste and reject butterflies based on'beak mark tasting'? A different point of view | |
Leadabrand et al. | Establishment, survival, site selection and development of Leptorhynchoides thecatus in largemouth bass, Micropterus salmoides | |
Johnson et al. | Fall panicum (Panicum dichotomiflorum) hepatotoxicosis in horses and sheep | |
Omeje et al. | Effect of pawpaw (Carica papaya) seed meal on sex determination, growth, and survival, of Oreochromis mossambicus fry | |
Udagawa et al. | Physiological abnormality and the tissue vitamin K level of mummichog Fundulus heteroclitus fed with a vitamin K free diet | |
NADHIM et al. | Histological, biochemical and chromosomal aberrations of pituitary gland induced by acrylamide in male rats | |
Ayuba et al. | Haematological Response and Weight Changes of the African Catfish Clarias gariepinus Exposed To Sub Lethal Concentrations of Datura innoxia Root Extract | |
Ekele et al. | THE DIGESTIVE TRACT OF THE FALSE UPSIDE DOWN CATFISH (Synodontis nigrita) FROM RIVER BENUE NIGERIA: A MICROMORPHOLOGICAL INVESTIGATION | |
Nakaghi et al. | Ontogenetic development of the oral apparatus and oropharyngeal cavity in bullfrog tadpoles (Lithobates catesbeianus, Shaw 1802) | |
Odaibo et al. | Occurrence and distribution of Rhabditis axei (Rhabditida; Rhabditidae) in African giant snails in southwestern Nigeria | |
Ngozi et al. | Effect of hydro-methanol stem extract of Anacardium occidentale on haematology and serum biochemistry in cockerels | |
Pandit et al. | Tricyclazole induced alterations in certain biomarker enzymes of an indian Paddy-field Fish, Channa punctatus (bloch) | |
Sateesh et al. | Toxicological studies on ayurvedic formulation Mersina in albino rats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |